Medical Communications

Pfizer, and its partner Astellas Pharma, received a major boost to its plans for prostate cancer treatment, Xtandi, by announcing …

The FDA has announced the news that it has awarded approval to the first-ever biosimilar for the treatment of cancer …

GSK, alongside its partner Innoviva, has announced that it has received a positive opinion from the EMA’s CHMP for its …

Sandoz, the biologics and generics division of Novartis, has unveiled new Phase 3 data confirming the efficacy and safety profile …

Recipharm, a leading contract development and manufacturing organisation (CDMO) and Kancera, a development company focused on cancer therapy, have signed …

Thomas Hirse, Partner, and Paetrick Sakowski, Associate, CMS, discuss what pharmaceutical companies need to be aware of ahead of the …

Martin Shkreli’s habit of being unable to stay out of the headlines continues, although this time with the repercussion that …

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch …

French biopharmaceutical group Ipsen has announced that Dr Ian Weatherhead has taken up the position of Vice President, Corporate External …

September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark …

Research undertaken by the Royal College of Psychiatrists using data from NHS Digital has found that the number of psychiatrists …

Teva has announced that its protracted search for a new CEO has finally come to end, as it revealed the …

Casebia therapeutics, a joint venture between Bayer and CRISPR Therapeutics, has moved to strengthen its leadership team by bringing in …

Following Deloitte’s anaylsis of the return on R&D spend by biopharmaceutical companies, this report reveals the key difficulties faced, as …

This week saw a number of hard-hitting stories hit the headlines that are sure to have resonant consequences. Following the …